[The therapeutic use of D-penicyllamine in the light of most recent pharmacokinetic and clinical observations (author's transl)].
D002614:Chelating Agents; D003300:Copper / Q000378:metabolism; D003555:Cystinuria / Q000188:drug therapy; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D008664:Metal Metabolism, Inborn Errors / Q000188:drug therapy*; D010084:Oxidation-Reduction; D010396:Penicillamine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D013329:Structure-Activity Relationship
D002614:Chelating Agents; D003300:Copper; D010396:Penicillamine
Zastosowanie terapeutyczne D-penicylaminy w świetle najnowszych danych farmakokinetycznych i obserwacji klinicznych.